Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05242406Not ApplicableCompleted

Effect of EMST Systemic Inflammation and Oxidative Stress in Patients With Moderate OSAS

Role: lead

NCT04454242Not ApplicableCompleted

High and Low Intensity Expiratory Muscle Strength Training in Patients With Obstructive Sleep Apnea Syndrome

Role: lead

NCT04930484Completed

Validity and Reliability of the Turkish Version of Performance Measure for Activities of Daily Living-8

Role: lead

NCT04451993Completed

Physical Activity Level in Patients With OSAS During Covid-19 Pandemic

Role: lead

NCT04201236Not ApplicableCompleted

Oropharyngeal Exercises and Inspiratory Muscle Training in Obstructive Sleep Apnea

Role: lead

NCT02029456Phase 4Unknown

Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism

Role: lead

All 6 trials loaded